P110
Awaiting review, BioHarmony verdict
Not yet scored. Queued for review; until then rely on the status and sources below.
What is P110?
P110 is a preclinical peptide inhibitor of the stress-associated Drp1-Fis1 interaction. Recent animal and cell studies do not establish human safety or effectiveness.
Saved on this device only.
Dosing as published
Source-reported figures only. This page does not calculate a personal dose.
No approved-label or study protocol is recorded for P110 yet.
More reported protocols
MembersMembers can compare additional reported doses, schedules, and preparation notes.
Trust & sourcing
- Last revieweddone
- Next reviewupcoming
US approvalInvestigational
CompoundingEligibility not established.
Primary sources
- Excessive mitochondrial fission and associated extracellular mitochondria mediate cardiac dysfunction in obesity cardiomyopathy PubMed / American Journal of Physiology,
Related peptides for brain, mood & sleep
- 6.8SelankSelank is a synthetic tuftsin-derived heptapeptide studied as a non-sedating anxiolytic.
- 6.7Epitalon (Epithalon)Epitalon is a synthetic AEDG tetrapeptide with in vitro telomerase and telomere data, animal lifespan signals, and Russian pineal-peptide melatonin studies.
- 6.4PinealonPinealon (Glu-Asp-Arg, or EDR) is a synthetic Khavinson tripeptide marketed for neuroprotection and cognition.
- 5.0P21 (P021)P21 (P021) is a CNTF-derived peptidomimetic that crosses the blood-brain barrier and, in mice, raises BDNF, lifts hippocampal neurogenesis, and lowers tau pathology in…
The Ultimate Peptides Guide
Spot stronger candidates, weak evidence, and seller red flags before you buy.